VECPHARM Trademark

Trademark Overview


On Tuesday, March 24, 2020, a trademark application was filed for VECPHARM with the United States Patent and Trademark Office. The USPTO has given the VECPHARM trademark a serial number of 88845130. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 3, 2021. This trademark is owned by Cellular Biomedicine Group HK Limited. The VECPHARM trademark is filed in the Pharmaceutical Products category with the following description:

Cell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Synthetic cholesterol mainly for use in growing cell cultures; Biological tissue cultures for medical purposes; Clinical medical reagents for use in gene therapy; Pharmaceutical preparations for use in gene therapy; Therapeutic compositions containing retroviral vector preparations and/or nucleic acid suitable for gene therapy; Retroviral vector preparations for use in gene therapy; Pharmaceutical preparations containing a retroviral vector delivering genes to cells for use in the treatment of viral and bacterial infections, cancer, leukemia and bodily conditions associated with impaired immunosystems
vecpharm

General Information


Serial Number88845130
Word MarkVECPHARM
Filing DateTuesday, March 24, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 3, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 4, 2020

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesCell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Synthetic cholesterol mainly for use in growing cell cultures; Biological tissue cultures for medical purposes; Clinical medical reagents for use in gene therapy; Pharmaceutical preparations for use in gene therapy; Therapeutic compositions containing retroviral vector preparations and/or nucleic acid suitable for gene therapy; Retroviral vector preparations for use in gene therapy; Pharmaceutical preparations containing a retroviral vector delivering genes to cells for use in the treatment of viral and bacterial infections, cancer, leukemia and bodily conditions associated with impaired immunosystems
Pseudo MarkVEC PHARM

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 27, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCellular Biomedicine Group HK Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAdmiralty, Hong Kong 999077
HK

Party NameCellular Biomedicine Group HK Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAdmiralty, Hong Kong 999077
HK

Trademark Events


Event DateEvent Description
Monday, May 3, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 3, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 29, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 4, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2020PUBLISHED FOR OPPOSITION
Monday, July 27, 2020ASSIGNED TO EXAMINER
Wednesday, July 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 2, 2020ASSIGNED TO LIE
Monday, June 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 24, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, June 24, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 24, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, June 24, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 16, 2020ASSIGNED TO EXAMINER
Friday, March 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 27, 2020NEW APPLICATION ENTERED IN TRAM